The European Commission has published a revision of pharmaceutical legislation, marking the most significant reform of the bloc's pharma rules in 20 years. This comprehensive overhaul is set to make a substantial impact in Europe and globally. PAREA has actively contributed input leading up to its publication and remains engaged in shaping the legislation during the institutional negotiations phase.
